Back to Search Start Over

Eczema Pipeline Outlook, FDA Approvals, Clinical Trials and Companies 2024 (Updated)

Source :
M2 Presswire. May 9, 2024
Publication Year :
2024

Abstract

M2 PRESSWIRE-May 9, 2024-: Eczema Pipeline Outlook, FDA Approvals, Clinical Trials and Companies 2024 (Updated) (C)1994-2024 M2 COMMUNICATIONS RDATE:08052024 DelveInsight, 'Eczema Pipeline Insight 2024' report provides comprehensive insights about 100+ [...]

Subjects

Subjects :
Business -- Research
Clobetasone -- Product development
Eczema
Dermatology -- Formulae, receipts, prescriptions
Drug approval
Clinical trials
Dermatologic agents -- Product development
Alitretinoin -- Product development
Business
Business, international

Details

Language :
English
Database :
Gale General OneFile
Journal :
M2 Presswire
Publication Type :
News
Accession number :
edsgcl.793185767

Tools

Authors Abstract Subjects Details